Portfolio company
Gero
Singapore · £4.7m raised
Raised
£4.7m
Latest stage
Series A
Rounds recorded
1
Backed by
2 investors
Sectors
About
This company develops an artificial intelligence drug discovery platform to identify therapeutic targets for chronic and age-related diseases for pharmaceutical partners.
SourceFunding history · 1
Similar companies
Generate Biomedicine
This company develops protein-based therapeutics using a generative artificial intelligence platform for pharmaceutical partners and biotechnology firms.
Fauna Bio
This company develops an artificial intelligence platform to identify drug targets for pharmaceutical partners by analysing genetic data from disease-resistant animal species.
Gordian Biotechnology
This company develops an in vivo drug discovery platform to identify therapies for age-related diseases for the pharmaceutical and healthcare sectors.
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
Gatchealth
This company develops an artificial intelligence platform for drug discovery and risk assessment for biopharmaceutical companies and investors.
Shift Bioscience
This biotechnology company develops cellular rejuvenation therapeutics and an AI-driven discovery platform for pharmaceutical researchers to treat age-related diseases.
Valohealth
This company develops an artificial intelligence platform for drug discovery and development to assist pharmaceutical partners in creating new medical treatments.
Parallel Bio
This company develops a drug discovery platform using human immune organoids and artificial intelligence for pharmaceutical and biotechnology partners.
